<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02434783</url>
  </required_header>
  <id_info>
    <org_study_id>2015/204</org_study_id>
    <nct_id>NCT02434783</nct_id>
  </id_info>
  <brief_title>The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity</brief_title>
  <official_title>The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current evidence cannot explain the clinical features of peripheral arterial disease only
      from the principle of reduced blood flow. Explanations have therefore in addition been linked
      to mitochondrial dysfunction of skeletal muscles.

      This study will elucidate whether there is a relation between clinical variables of the
      different levels of arterial insufficiency in peripheral arterial disease and mitochondrial
      respiratory capacity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mitochondrial respiratory capacity</measure>
    <time_frame>1 hour</time_frame>
    <description>measured in oxygen glux in pmol.s-1.mg-1, using mitochondrial respirometry on an Oxygraph-2k (Oroboros Instruments, Austria).</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>1st level of arterial insufficiency</arm_group_label>
    <description>asymptomatic PAD patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd level of arterial insufficiency</arm_group_label>
    <description>Intermittent claudication patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3rd level of arterial insufficiency</arm_group_label>
    <description>Critical limb ischemia patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No arterial insufficiency</arm_group_label>
    <description>Healthy individuals (control)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      gastrocnemicus muscle biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with arterial insufficience at 1 of three levels, either asymptotic, intermittent
        claudication or critical limb ischemia; and healthy persons in a control group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asymptotic peripheral arterial disease (Ankle-brachial index &lt; 0.9), intermittent
             claudication (Ankle-brachial index 0.4 - 0.9), or critical limb ischemia
             (Ankle-brachial index &lt; 0.4)

        Exclusion Criteria:

          -  Diagnosed with intermittent claudication secondary to vascular insufficiency

          -  Warfarin or heparin usage

          -  Underwent a vascular intervention in the last 6 months

          -  Active cancer, renal- or liver disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ã˜yvind Rognmo</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Circulation and Medical Imaging</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2015</study_first_posted>
  <last_update_submitted>August 4, 2016</last_update_submitted>
  <last_update_submitted_qc>August 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood circulation</keyword>
  <keyword>Blood vessels</keyword>
  <keyword>Mitochondria</keyword>
  <keyword>Muscle, skeletal</keyword>
  <keyword>Legs</keyword>
  <keyword>Energy metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

